Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries
Figure 1
A Patient with MDR-TB Holds the Dose of Drugs He Must Take Every Day
This patient checked into the hospital in November 2006 and in January 2007 he tested negative; if his progress continues, he could be sent home to finish his treatment. (Photo: Jean-Marc Giboux)